← Leaderboards
Jing Luo
University Of Pittsburgh At Pittsburgh
$829,425
Attributed
$829,425
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $263.6K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$829,425 · 1
By mechanism
K23$829,425 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Julie Marie Donohue$17,269,798
- Stephen Y Lai$10,561,066
- Hilary A. Tindle$15,133,646
- Antonio Youssef Hardan$10,973,044
- G Kelley Fitzgerald$3,071,132
Others in their field
Other Emerging Leaders on “Databases”
- Leonard Freedman · Leidos Biomedical Research, Inc.$186,439,178
- Klaus Romero · Critical Path Institute$90,404,592
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$68,745,882
- Leonard Freedmand · Leidos Biomedical Research, Inc.$50,302,300
- Lynn Briscoe · Leidos Biomedical Research, Inc.$50,165,970
Research focus
DatabasesAdherenceAcademic DetailingCost SharingBarrier To CareBasal InsulinAcceptability And FeasibilityBurnoutCardiovascular DiseasesAwardCardiovascular Risk FactorCardiovascular SystemCareerCareer DevelopmentAgonistClinical Outcome MeasuresCluster Randomized TrialCodeCohortCommunity PracticeCardiovascular Disorder RiskCopaymentCostDeductibles
Grant awards (5)
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes$188,134
K23 · FY2024 · DK · contact PI
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes$188,100
K23 · FY2023 · DK · contact PI
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes$75,456
K23 · FY2023 · DK · contact PI
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes$188,126
K23 · FY2022 · DK · contact PI
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes$189,609
K23 · FY2021 · DK · contact PI